Australia
JXSN#4 FLOWS HELIUM (6.5% He) TO SURFACE GALACTICA/PEGASUS
Highlights * JXSN#4 exploration well completed in Blue Star's Galactica/Pegasus prospect. * Analysis of gas obtained during drilling shows a calculated air-free gas composition of 6.5% helium in theLyons formation. * Both the upper and lower Lyons sands are gas charged with helium. * JXSN#4...
2022-09-29 12:48
1076
CONTINGENT RESOURCE CERTIFIED FOR VOYAGER FIELD
Highlights * 2C net unrisked contingent helium resource of 643 MMscf for Voyager (100% BNL). * High side (3C) net unrisked estimate of 1,228 MMscf. * First declaration of contingent resource at Voyager is in addition to existing prospective resources at Galactica/Pegasus, Enterprise, Argo, ...
2022-09-27 16:43
2226
New report offers blueprint for regulation of facial recognition technology
SYDNEY, Sept. 26, 2022 /PRNewswire/ -- A new report
2022-09-27 07:33
1231
Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson's Disease and Movement Disorders
- Wearable sensors strongly correlated with clinical scales on motor impairment - - bioMUSE Study Validates Use of Wearable Sensors for Alterity's Ongoing Phase 2 Clinical Trial - MELBOURNE, Australia and SAN FRANCISCO, Sept. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATH...
2022-09-26 19:25
1403
Capitalise.ai and Pepperstone announce strategic partnership to enhance trading experience
Pepperstone will offer their traders an innovative AI-driven auto-trading experience Pepperstone, an award-winning CFD & Forex broker has teamed up with Capitalise.ai to offer their traders a seamless, auto-trading experience. This new partnership enables Pepperstone clients to easily analyze, a...
2022-09-21 12:01
1246
Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy
Regulatory Authorization Granted to Proceed with ATH434 Phase 2 Clinical Trial MELBOURNE, Australia and SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying tr...
2022-09-20 19:25
1251
MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS
MELBOURNE, Australia, Sept. 13, 2022 /PRNewswire/ -- The University of Texas MD
Anderson Cancer Center
2022-09-14 11:09
1104
LiveHire and Raise Recruiting Clients Wow Direct Sourcing Space
MIAMI, Sept. 12, 2022 /PRNewswire/ -- LiveHire
2022-09-13 00:03
1317
LIVEHIRE AND HIREGENICS LAUNCH 3 NEW DIRECT SOURCING PROGRAMS TO PREMIER FORTUNE 500 COMPANIES
MIAMI, Sept. 8, 2022 /PRNewswire/ -- LiveHire
2022-09-09 02:45
1530
BAI's Group CEO to speak at TMT M&A Forum USA 2022
SYDNEY, Sept. 8, 2022 /PRNewswire/ -- BAI Communications
2022-09-08 21:00
1918
New Fortune 1000 Direct Sourcing Clients for LiveHire and Partner Broadleaf
MIAMI , Sept. 7, 2022 /PRNewswire/ -- LiveHire
2022-09-08 05:08
2038
Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US
SYDNEY, Sept. 5, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the US-based diagn...
2022-09-05 21:09
2525
LiveHire Announces Launch of "Thrive" Global Partner Ecosystem to Bring Together World Class Technologies and Service Providers
MIAMI, Aug. 30, 2022 /PRNewswire/ -- LiveHire Ltd. (ASX:LVH), a global software-as-a-service (SaaS) platform connecting companies and candidates, today announced the launch of the global Thrive Partner Network, bringing together the best technologies and service providers to deliver total talent ...
2022-08-30 23:02
2452
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe
Second region now open for enrolment for rare, rapidly progressive, neurodegenerative disease MELBOURNE, Australia and SAN FRANCISCO, Aug. 25, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing diseas...
2022-08-25 19:25
2305
LiveHire and CrintellTech Announce Strategic Integration to Automate Candidate Sourcing and Streamline the Recruiting Life-Cycle
MIAMI and CHEYENNE, Wyo., Aug. 23, 2022 /PR Newswire/ -- LiveHire Ltd. (ASX: LVH), a global software-as-a-service (SaaS)Total Talent Acquisition platform that helps companies connect with and hire the talent they need, and CrintellTech, an AI-driven recruitment intelligence platform that automate...
2022-08-23 23:03
2394
Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma
Highlights * Cohort 2 completed in participants with neuroblastoma who received therapy with67Cu SARTATE™ at a dose of 175MBq/kg body weight * No Dose Limiting Toxicities (DLTs) have been reported in cohort 1 and cohort 2 * Safety Review Committee (SRC) has recommended the trial continues w...
2022-08-23 21:04
2656
Delegate Connect Rebrands As Joyn
MELBOURNE, Australia, Aug. 18, 2022 /PRNewswire/ -- Delegate Connect, an end-to-end solution for delivering immersive virtual and hybrid events, has officially rebranded as Joyn. Initially focused on the APAC region, the rebranding comes at a pivotal time in the company's growth as it successfull...
2022-08-18 06:00
1840
Announcing the Release of The Disruptors, the First Comprehensive Documentary Film on ADHD Award-Winning, Star-Studded Documentary Available in Australia on Apple TV/iTunes, Google Play, and YouTube
GREENWICH, Conn., Aug. 17, 2022 /PRNewswire/ -- Following its successful US debut, THE DISRUPTORS – the first definitive, comprehensive documentary film on ADHD, one of the most commonly diagnosed, and widely misunderstood neurological conditions in the world today – is now available inAustralia ...
2022-08-18 05:23
5022
Skedda Partners with Five Elms Capital to Modernize Space Management and Scheduling
MELBOURNE, Australia, Aug. 17, 2022 /PRNewswire/ -- Skedda, a leading global space management and scheduling platform serving over 12,000 customers, today announced a strategic growth investment from Five Elms Capital, a leading global investor in high-growth B2B software companies. The investmen...
2022-08-17 23:00
2316
TREASURES AUCTIONS NETWORK WINS BRONZE STEVIE® AWARD IN 2022 INTERNATIONAL BUSINESS AWARDS®
Winners to Be Celebrated During Event in London on 15 October
GOLD COAST, Australia, Aug. 16, 2022 /PRNewswire/ -- Treasures Auctions
Network was named the winner of a Bronze Stevie® Award in the Retail category
in The 19th Annual International Business Awards® today.
2022-08-16 23:00
2743
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
6529
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4461
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4055
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
3501
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
3410